Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase 1/2 1

Status

Completed 10Unknown 6Recruiting 3Not yet recruiting 2Active not recruiting 2

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 2Thoracic 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Uveal Melanoma 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Unknown × treosulfan × Clear all
NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Unknown
102 enrolled 12 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

NCT02852083 2018-01-18

ModuLung

University Hospital Regensburg

Phase 2 Unknown
86 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01079013 2016-04-20

Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Sheba Medical Center

Phase 2 Unknown
40 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT01810926 2013-03-14

T&B Depletion Non Malignant

Bambino Gesù Hospital and Research Institute

Phase 2 Unknown
130 enrolled

Graft vs Host Disease

NCT00129155 2007-10-04

MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Hospices Civils de Lyon

Phase 2 Unknown
30 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT00168870 2007-08-31

Study of Metastatic Ocular Melanoma

Charite University, Berlin, Germany

Phase 2 Unknown
48 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡